PedAM

Pediatric Disease Annotations & Medicines

Disease	thrombocytopenia
Phenotype	C0026986\|myelodysplastic syndrome
Sentences	10
PubMedID- 22967412	Objective: to investigate the prognostic value of thrombocytopenia in patients with primary myelodysplastic syndromes (mds).
PubMedID- 25659186	thrombocytopenia in patients with myelodysplastic syndromes (mds) is a frequent cause of haemorrhage-related morbidity and mortality, and is associated with increased risk of leukaemic transformation and reduced overall survival.
PubMedID- 25368823	A case of refractory thrombocytopenia with 5q deletion: myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura.
PubMedID- 20620439	thrombocytopenia in patients with myelodysplastic syndromes.
PubMedID- 24706489	Background: thrombocytopenia in patients with myelodysplastic syndrome (mds) is associated with shortened survival and an increased risk of evolution to acute myeloid leukemia (aml).
PubMedID- 25632241	Giagounidis et al reported the results of a comparison of romiplostim and placebo for treatment of thrombocytopenia in patients with myelodysplastic syndrome.72 despite promising results showing increased platelet counts, decreased number of bleeding events, and decreased platelet transfusions in the romiplostim arm, the study was discontinued early due to concerns of excess blasts and the rate of aml.
PubMedID- 21575929	Purpose: to analyze the incidence and significance of thrombocytopenia in patients with myelodysplastic syndrome (mds).
PubMedID- 22129476	Platelet associated igg may be related with thrombocytopenia in patients with myelodysplastic syndromes.
PubMedID- 23190430	Background: lenalidomide treatment in myelodysplastic syndrome (mds) may lead to thrombocytopenia and dose reductions/delays.
PubMedID- 23403320	Plasma thrombopoietin levels were measured in 120 patients who had myelodysplastic syndrome with thrombocytopenia (< 100 x 10(9)/l) to determine any correlation to markers associated with immune pathophysiology and outcome.

Page: 1